Next, we evaluated the implication on SFRP5, WNT5A and PPARγ in SAT and VAT according to metabolic syndrome presence and their components (T2DM, dyslipidaemia and hypertension). This evidence concerns the gene PPARG and inherited lipid metabolism disorder.